Initiative to Minimize Disparities in Postoperative Prostate Cancer Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-01

Study Completion Date

2022-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Einstein Healthcare Network in North Philadelphia serves a predominantly underserved medical community. The investigators routinely see patients who cannot afford absorbent pads after prostate surgery, which helps with quality of life secondary to urinary incontinence. The investigators will provide absorbent pads to participants who would be unable to afford them. The investigators hypothesize that providing absorbent pads for 6 months will result in improved quality of life in regards to management of urinary incontinence after radical prostatectomy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating Return to Continence and Potency Following Radical Prostatectomy

NCT05742334

Prostate Cancer

WITHDRAWN NA

Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer

NCT03921996

Prostate Cancer

TERMINATED PHASE3

Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy

NCT00922818

Prostate Cancer

WITHDRAWN

3D Versus Robot Assisted Laparoscopic Prostatectomy.

NCT03550040

Prostate Cancer

TERMINATED NA

Trial to Compare Urinary Continence Recovery After Robotic Radical Prostatectomy With or Without Rhabdosphincter Reconstruction.

NCT03302169

Urinary Incontinence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

When detected early and managed with appropriate surgical treatment, such as radical prostatectomy, Prostate cancer prognosis is excellent, but recovery may be associated with significant transient impact on quality of life. This impact most often manifests in urinary domains, specifically, development of stress urinary incontinence. Several simple, low-cost but high-yield interventions may dramatically improve patient's postoperative quality of life. However, such interventions may be out of reach for patients from Health Enterprise Zones (HEZ) with limited funds. To make resources readily available for this patient population, the inclusion criteria will be prostatectomy patients of any age who reside within the designated North Broad street HEZ.

Stress urinary incontinence after prostatectomy is a source of major distress. Incontinence tends to improve over time with most patients regaining their urinary function. Symptomatic support with disposable absorbent pads/diapers for several months helps men effectively manage this side effect. While for most men the cost of the diapers is manageable, for men in HEZ this represents a significant financial burden on the patient and on caregivers. As a result, these patients often choose to remain home bound until they recover urinary control, preventing them from early return to employment and resulting in social isolation. The Healthcare Disparity SEED Grant will provide up to a 6-month supply of disposable absorbent pads/diapers to those patients meeting our inclusion criteria. Michigan Incontinence Symptom Index (M-ISI) questionnaires will be distributed to patients pre-operatively and during interval post-operative office visits to assess patient satisfaction with voiding function.

In addition to distributing M-ISI questionnaires, we will also distribute the Extended Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) to evaluate overall quality of life. This is a validated questionnaire capable of accurately assessing multiple domains of quality of life after prostate cancer treatment. Results of M-ISI and EPIC-CP scores will be compiled and analyzed to determine if intervention has resulted in measurable improvement between the treatment and control groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Prostatectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 (Provided absorbent pads)

Patients will receive a 6 month supply (as needed) of absorbent pads for urinary incontinence.

Absorbent pad for urinary incontinence

Intervention Type OTHER

6 month supply provided to patients as needed for urinary incontinence after radical prostatectomy

Group 2 (not provided absorbent pads)

Patients enrolled in the control arm will not receive absorbent pads.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Absorbent pad for urinary incontinence

6 month supply provided to patients as needed for urinary incontinence after radical prostatectomy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. History of prostate cancer
2. Scheduled for radical prostatectomy during a designated academic year
3. Reside within Health Enterprise Zone (HEZ) of North Broad Street
4. Median annual household income \< $50,000
5. Patient feels that they would struggle to afford absorbent pads and Tadalafil based on their annual income
6. Patient must have no history of stress urinary incontinence prior to surgery

3. Patients with cognitive impairment will be excluded from the study

Eligible Sex

MALE

Accepts Healthy Volunteers

No